Flower One Holdings Inc (FLOOF)
0.00
USD |
OTCM |
May 21, 16:00
Flower One Holdings Max Drawdown (5Y): 100.0% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 100.0% |
March 31, 2024 | 100.0% |
February 29, 2024 | 100.0% |
January 31, 2024 | 100.0% |
December 31, 2023 | 100.0% |
November 30, 2023 | 100.0% |
October 31, 2023 | 100.0% |
September 30, 2023 | 100.0% |
August 31, 2023 | 100.0% |
July 31, 2023 | 100.0% |
June 30, 2023 | 100.0% |
May 31, 2023 | 100.00% |
April 30, 2023 | 100.00% |
March 31, 2023 | 100.00% |
February 28, 2023 | 100.00% |
January 31, 2023 | 100.00% |
December 31, 2022 | 100.00% |
November 30, 2022 | 100.00% |
October 31, 2022 | 100.00% |
September 30, 2022 | 99.96% |
August 31, 2022 | 99.56% |
July 31, 2022 | 99.30% |
June 30, 2022 | 99.24% |
May 31, 2022 | 99.16% |
April 30, 2022 | 99.16% |
Date | Value |
---|---|
March 31, 2022 | 99.16% |
February 28, 2022 | 99.16% |
January 31, 2022 | 99.10% |
December 31, 2021 | 98.83% |
November 30, 2021 | 98.07% |
October 31, 2021 | 97.02% |
September 30, 2021 | 96.80% |
August 31, 2021 | 96.73% |
July 31, 2021 | 96.73% |
June 30, 2021 | 96.73% |
May 31, 2021 | 96.73% |
April 30, 2021 | 96.73% |
March 31, 2021 | 96.73% |
February 28, 2021 | 96.73% |
January 31, 2021 | 96.73% |
December 31, 2020 | 96.73% |
November 30, 2020 | 96.73% |
October 31, 2020 | 96.73% |
September 30, 2020 | 96.39% |
August 31, 2020 | 89.86% |
July 31, 2020 | 89.86% |
June 30, 2020 | 89.86% |
May 31, 2020 | 89.86% |
April 30, 2020 | 89.86% |
March 31, 2020 | 89.59% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
29.71%
Minimum
May 2019
100.0%
Maximum
Jun 2023
90.94%
Average
97.54%
Median
Max Drawdown (5Y) Benchmarks
Cotinga Pharmaceuticals Inc | 100.00% |
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |